Yemaozi's Profile Page - moomoo Community

Yemaozi

ID: 70177308

No profile added yet

Following

Followers

409

Visitors

Recommended Users

Mooers Lab

Study and explore mooers' value

25K followers

Investing with moomoo

Yemaozi commented on

commented on a stock·Apr 3 13:58

$Disney(DIS.US)$ Executives are selling one after another!

Translated

Yemaozi reacted to

金融弟弟

commented on a stock·Mar 31 15:42

Operate his vix

$CBOE Volatility S&P 500 Index(.VIX.US)$ When the VIX Index exceeds 40, it indicates that the market's fears about the future are irrational, and there may be a rebound in the short term. When the VIX index falls below 15, it indicates an irrational boom in the market; the VIX index is a synchronous indicator for buying signals and a lagging indicator for selling signals; the VIX index has the characteristic of reversing to mean, and its fluctuation range is between 10-25; when VIX falls below 16, the single-day surge is basically below 5; when VIX is between 16 and 28, the single-day surge increases to 8; when VIX is above 30, the single-day surge is often higher than 10. When VIX reaches its peak, the single-day surge is at its lowest or decline; the VIX average from 1990 to now is 19.16, and the lowest in history is 8.56. Theoretically, the VIX minimum can be 0, not capped; assuming the VIX index is 18, then the expected annual volatility is 18%, so you can expect the S&P 500 index to fluctuate up or down by 18% /√12 = 5.2% over the next 30 days; when VIX is greater than 40, you can consider shorting futures and buying subscription options at the same time to prevent excessive increases from causing excessive losses; when VIX falls below 10 To consider futures trading, you should avoid monthly exchanges; the above content is a reprint and does not constitute investment advice $ProShares Ultra VIX Short-Term Futures ETF(UVXY.US)$ $2x Long VIX Futures ETF(UVIX.US)$ First choice for shorting...

Translated

Yemaozi commented on

steven smith38

commented on a stock·Mar 27 14:20

$Veritone(VERI.US)$ is it going to go back up

Yemaozi

commented on a stock·Mar 26 07:47

$Viking Therapeutics(VKTX.US)$
Results from the 28-day MAD study highlighted positive signs of clinical activity after oral VK2735 treatment. The group receiving VK2735 showed a decrease in average body weight compared to baseline, by as much as 5.3%. Compared to placebo, the average body weight of the group receiving VK2735 also decreased by as much as 3.3%. For doses greater than or equal to 10 mg, the average weight loss after placebo was maintained or improved on day 34, six days after the last dose of VK2735, as much as 3.6% compared to placebo. An exploratory evaluation of the proportion of subjects who lost at least 5% of their weight after 28 days showed that as many as 57% of those treated with VK2735 lost more than 5% of their weight, compared to 0% with placebo. Based on an initial assessment of the weight loss trajectory, the company believes that treatment over 28 days can lead to further weight loss.

“These first phase results highlight the promising early weight loss and tolerability of VK2735 in oral tablet doses,” said Dr. Brian Lien, CEO of Viking. “We think these data suggest that, at possibly higher doses, it may result in longer treatment times

Translated

Yemaozi reacted to

71498156

commented on a stock·Mar 12 13:00

$NVIDIA(NVDA.US)$It went up in the long pack B, dropped the short pack B, and no one has ever bought B one day earlier

Translated

Yemaozi

commented on a stock·Mar 11 13:40

$PDD Holdings(PDD.US)$PDD agency Jefferies raised its rating to the “buy” target price to $157.

Translated

Yemaozi

commented on a stock·Mar 8 05:51

$Broadcom(AVGO.US)$ J.P. Morgan raised Broadcom's target share price from $1550.00 to $1,700.00 per share

Translated

Yemaozi commented on

no_totti_no_party

wrote a post·Mar 7 21:09

$Broadcom(AVGO.US)$ | Broadcom Q1 Earnings Highlights:
🔹 EPS: $10.99 (Est. $10.40) 🟢
🔹 Revenue: $11.96B (Est. $11.79B) 🟢
🔹 Semiconductor Solutions Rev: $7.39B (Est. $7.7B) 🔴
FY'24 Business Outlook:
🔹 Revenue Guidance: ~$50.0B (Est. $50.21B) 🟡
🔹 Adjusted EBITDA Guidance: ~60% of projected revenue
Additional Insights:
🔸 Free cash flow, excluding restructuring in the quarter, was strong at $5.4B.
🔸 Fiscal Year 2024 includes the contribution from VMware, projecting an increase of 40% from the prior ...

Yemaozi

commented on a stock·Mar 7 23:15

$Broadcom(AVGO.US)$ In the first fiscal quarter, the company generated $4.815 billion in cash from operations and had capital expenses of $122 million. The company spent $8.29 billion on share buybacks and removals, including $7.176 billion for 6.7 million share repurchases and $1,114 billion in withholding taxes associated with the quarter's net settlement equity rewards (equivalent to approximately 1 million shares withheld).
On December 29, 2023, the company paid a cash dividend of US$5.25 per share, totaling US$2,435 million.
Chief Legal and Corporate Affairs Officer Mark David Brazier acquired 16,375 common shares on March 5, 2024. The shares have a face value of $0.001 and were purchased free of charge, which suggests that this may be part of the executive's compensation package. Following this deal, Brazeal's direct shareholding in Broadcom increased to a total of 52,393 shares. The deal has been marked as completed.

Translated

Yemaozi

commented on a stock·Mar 7 12:07

$Viking Therapeutics(VKTX.US)$ VKTX [Why did it drop] -16%, as its competitor drug giant NVO Novo Nordisk will launch the obesity drug Wegovy in Japan to address Japan's growing weight problem. Novo Nordisk's chief strategy officer said earlier at the Capital Markets Day event that the first phase of the trial of the experimental drug Amycretin (Amycretin) showed participants lost 13.1% of their body weight after 12 weeks. Investors were thrilled. Additionally, the agency Jefferies gave a purchase evaluation of Viking Therapeutics, with a target price of $110.

Translated